Cabbacis (OTCQB: CABI) is pioneering harm-reduction in the global tobacco industry, targeting the world’s one billion smokers with its flagship iBlend™ line of reduced-nicotine cigarettes and compatible vaporizer pods. These proprietary, patent protected products combine ultra-low‑nicotine tobacco with non-intoxicating hemp, helping smokers on their nicotine quitting journey. Proven in studies and backed by 35 issued patents worldwide covering the combination of hemp and low-nicotine tobacco in a cigarette, Cabbacis holds a strong IP position ahead of a proposed FDA requirement to lower nicotine levels by 95% in all cigarettes across the United States. To learn more, please visit cabbacis.com.

Cabbacis

Joseph Pandolfino

This department guides the overall strategic direction and leadership of the organization.

Cabbacis

Org chart

Teams

Executive Leadership

Offices